Brief: Acumen Pharmaceuticals Reports Q1 2023 Financial Results And Business Highlights
May 9 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O :
* ACUMEN PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* ACUMEN PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.28
Source text for Eikon: ID:nGNX9sRG16
Further company coverage: ABOS.O
((Reuters.Briefs@thomsonreuters.com;))